Dr. Carl Koschmann, MD
Claim this profileUniversity of Michigan
Studies Brain Tumor
Studies Glioblastoma
11 reported clinical trials
18 drugs studied
Area of expertise
1Brain Tumor
Stage I
Stage II
H3K27 positive
2Glioblastoma
H3K27 positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Carl Koschmann, MD is currently running
Selinexor + Radiation
for Brain Cancer
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting1 award Phase 1 & 21 criteria
Avapritinib
for Pediatric Solid Cancers
This is a Phase 1/2, multicenter, open-label trial of avapritinib in participants 2 to \< 18 years of age with advanced relapsed/refractory (R/R) solid tumors, including central nervous system (CNS) tumors, that harbor a PDGFRA and/or KIT mutation (including non-synonymous point mutations, insertions, and deletions) or amplification, or DMG-H3K27a who have no available curative treatment options. This is a single-arm trial in which all participants will receive avapritinib. The study consists of 2 parts: dose confirmation, safety, and PK (Part 1) and initial efficacy, safety, and PK at the Part 2 recommended dose (Part 2).
Recruiting1 award Phase 1 & 2
More about Carl Koschmann, MD
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Carl Koschmann, MD has experience with
- Radiation Therapy
- ONC201
- Fimepinostat
- Therapeutic Conventional Surgery
- Dasatinib
- Everolimus
Breakdown of trials Carl Koschmann, MD has run
Brain Tumor
Glioblastoma
Diffuse Intrinsic Pontine Glioma
Anaplastic Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carl Koschmann, MD specialize in?
Carl Koschmann, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved Stage I patients, or patients who are Stage II.
Is Carl Koschmann, MD currently recruiting for clinical trials?
Yes, Carl Koschmann, MD is currently recruiting for 6 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Carl Koschmann, MD has studied deeply?
Yes, Carl Koschmann, MD has studied treatments such as Radiation Therapy, ONC201, Fimepinostat.
What is the best way to schedule an appointment with Carl Koschmann, MD?
Apply for one of the trials that Carl Koschmann, MD is conducting.
What is the office address of Carl Koschmann, MD?
The office of Carl Koschmann, MD is located at: University of Michigan, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.